151 related articles for article (PubMed ID: 24370470)
1. Loss of MHC II ubiquitination inhibits the activation and differentiation of CD4 T cells.
Ishikawa R; Kajikawa M; Ishido S
Int Immunol; 2014 May; 26(5):283-9. PubMed ID: 24370470
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitination of MHC Class II by March-I Regulates Dendritic Cell Fitness.
Kim HJ; Bandola-Simon J; Ishido S; Wong NW; Koparde VN; Cam M; Roche PA
J Immunol; 2021 Feb; 206(3):494-504. PubMed ID: 33318291
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.
Ohmura-Hoshino M; Matsuki Y; Mito-Yoshida M; Goto E; Aoki-Kawasumi M; Nakayama M; Ohara O; Ishido S
J Immunol; 2009 Dec; 183(11):6893-7. PubMed ID: 19917682
[TBL] [Abstract][Full Text] [Related]
4. Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.
Yang H; Qiu Q; Gao B; Kong S; Lin Z; Fang D
J Exp Med; 2014 Nov; 211(12):2467-79. PubMed ID: 25366967
[TBL] [Abstract][Full Text] [Related]
5. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells.
Young LJ; Wilson NS; Schnorrer P; Proietto A; ten Broeke T; Matsuki Y; Mount AM; Belz GT; O'Keeffe M; Ohmura-Hoshino M; Ishido S; Stoorvogel W; Heath WR; Shortman K; Villadangos JA
Nat Immunol; 2008 Nov; 9(11):1244-52. PubMed ID: 18849989
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.
Cho KJ; Walseng E; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10449-54. PubMed ID: 26240324
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
8. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
Periasamy P; O'Neill HC
Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
[TBL] [Abstract][Full Text] [Related]
9. MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway.
Wilson KR; Liu H; Healey G; Vuong V; Ishido S; Herold MJ; Villadangos JA; Mintern JD
PLoS One; 2018; 13(7):e0200540. PubMed ID: 30001419
[TBL] [Abstract][Full Text] [Related]
10. MHC class II-peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1 phenotype.
Buatois V; Baillet M; Bécart S; Mooney N; Leserman L; Machy P
J Immunol; 2003 Dec; 171(11):5812-9. PubMed ID: 14634090
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of MHC Class II Is Required for Development of Regulatory but Not Conventional CD4
Liu H; Wilson KR; Schriek P; Macri C; Blum AB; Francis L; Heinlein M; Nataraja C; Harris J; Jones SA; Gray DHD; Villadangos JA; Mintern JD
J Immunol; 2020 Sep; 205(5):1207-1216. PubMed ID: 32747505
[TBL] [Abstract][Full Text] [Related]
12. The presence of interleukin-27 during monocyte-derived dendritic cell differentiation promotes improved antigen processing and stimulation of T cells.
Jung JY; Roberts LL; Robinson CM
Immunology; 2015 Apr; 144(4):649-60. PubMed ID: 25346485
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells.
Walseng E; Furuta K; Bosch B; Weih KA; Matsuki Y; Bakke O; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20465-70. PubMed ID: 21059907
[TBL] [Abstract][Full Text] [Related]
14. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
15. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
Bosch B; Heipertz EL; Drake JR; Roche PA
J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
[TBL] [Abstract][Full Text] [Related]
17. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.
Cho KJ; Ishido S; Eisenlohr LC; Roche PA
J Immunol; 2020 Mar; 204(6):1621-1629. PubMed ID: 31996461
[TBL] [Abstract][Full Text] [Related]
18. Th cells and Th2 responses can develop in the absence of MHC class II-CD4 interactions.
Wack A; Corbella P; Harker N; Roderick K; Norton T; Williams K; Williams O; Kioussis D
J Immunol; 1999 Aug; 163(3):1162-9. PubMed ID: 10415010
[TBL] [Abstract][Full Text] [Related]
19. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS.
Mittal SK; Cho KJ; Ishido S; Roche PA
J Biol Chem; 2015 Nov; 290(45):27158-27167. PubMed ID: 26408197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
